Abbott Laboratories (ABT) Shareholders & Insider Trades
Abbott Laboratories shareholders at a glance
The largest holder of Abbott Laboratories stock is BlackRock Advisors LLC, with 115.7 million shares (6.69% of the company), worth about $12.77 billion as of September 25, 2026. The 10 largest holders together own 34.1%.
In Q2 2026, 3,094 institutional holdings reports listed 1.63 billion shares worth $128.00 billion, up 18.1% in shares from Q1 2026.
Insiders reported 79 transactions in the last two years: 23 sales worth $144.99 million and 5 purchases. The newest one on file is from September 2, 2026 (Mccoy John A. Jr, Officer).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through September 2, 2026.
Abbott Laboratories
Shareholders Summary
2026Q2
Ownership by Type
Geographic Distribution
Largest Abbott Laboratories shareholders
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Advisors LLC | 115.7 million | 6.69% | $12.8B |
| Vanguard Capital Management LLC | 113.8 million | 6.57% | $12.6B |
| State Street Corporation | 80.9 million | 4.68% | $8.9B |
| Charles Schwab Investment Management, Inc. | 59.7 million | 3.45% | $6.6B |
| Vanguard Portfolio Management LLC | 49.0 million | 2.83% | $5.4B |
| Geode Capital Management LLC | 39.2 million | 2.27% | $4.3B |
| Capital Research & Management Co. (Global Investors) | 36.9 million | 2.13% | $4.1B |
| Capital Research & Management Co. (International Investors) | 34.7 million | 2.00% | $3.8B |
| BlackRock Life Ltd. | 33.2 million | 1.92% | $3.7B |
| Eaton Vance Management | 26.6 million | 1.54% | $2.9B |
As of September 25, 2026.
Abbott Laboratories institutional holdings by quarter
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 3,094 | 1.63 billion | $128.0B |
| Q1 2026 | 3,229 | 1.38 billion | $142.0B |
| Q4 2025 | 3,397 | 1.45 billion | $177.0B |
| Q3 2025 | 3,308 | 1.39 billion | $186.0B |
| Q2 2025 | 3,310 | 1.39 billion | $307.0B |
| Q1 2025 | 3,293 | 1.38 billion | $182.0B |
| Q4 2024 | 3,198 | 1.36 billion | $154.0B |
| Q3 2024 | 3,022 | 1.35 billion | $154.0B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
Abbott Laboratories insider trades
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Mccoy John A. Jr | Sep 2, 2026 | Officer | Sale at price 109.54 per share. | $2,958 |
| Ford Robert B. | Aug 25, 2026 | Chief Executive Officer | Conversion of Exercise of derivative security at price 44.40 - 59.94 per share. | $21.5M |
| Ford Robert B. | Aug 25, 2026 | Chief Executive Officer | Sale at price 115.57 - 116.19 per share. | $46.2M |
| Morrone Louis H | Aug 11, 2026 | Officer | Sale at price 109.83 per share. | $642,506 |
| Stratton John G. | May 7, 2026 | Director | Purchase at price 86.82 per share. | $173,640 |
| Starks Daniel J | Apr 27, 2026 | Director | Purchase at price 92.65 per share. | $926,537 |
| O Grady Michael G | Apr 24, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Blount Sally E | Apr 24, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Stratton John G. | Apr 24, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Starks Daniel J | Apr 24, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Conroy Kevin T | Apr 24, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Mckinstry Nancy | Apr 24, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
Newest 12 of 79 insider transactions in the last two years.
Questions and answers
Who owns the most Abbott Laboratories stock?
BlackRock Advisors LLC, with 6.69% of the company (as of September 25, 2026). Next: Vanguard Capital Management LLC (6.57%) and State Street Corporation (4.68%).
How many institutions own Abbott Laboratories stock?
3,094 institutional holdings reports listed Abbott Laboratories shares in Q2 2026, 1.63 billion shares in all worth $128.00 billion.
Are Abbott Laboratories insiders buying or selling the stock?
In the last two years insiders reported 23 sales and 5 purchases (79 transactions in all); the newest on file is from September 2, 2026.
